Viewing StudyNCT00031278



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00031278
Status: COMPLETED
Last Update Posted: 2011-05-30
First Post: 2002-02-28

Brief Title: Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Carcinoma Metastatic Breast
Keywords:
Name View
Metastatic View
Breast View
Cancer View
immunotherapy View
CPG 7909 View